Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

Provided By GlobeNewswire

Last update: Nov 9, 2023

SAN FRANCISCO and SAN DIEGO, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate” or the “Company”), a clinical-stage precision oncology company, today announced financial results for the third quarter of 2023 and recent corporate updates.